Journal of clinical lipidologyHumansMaleCholesterolLDLBlood Component Removal
Breakthrough LDL-C reduction in a patient with autosomal recessive homozygous familial hypercholesterolemia: Efficacy of evinacumab after LDL-apheresis discontinuation.
Pablo González-Bustos, Francisco Fuentes-Jiménez, Javier Delgado-Lista, Raquel Ojeda-López, Juan Diego Mediavilla-García
Published: 202610.1016/j.jacl.2025.09.028
Abstract
BACKGROUND: Autosomal recessive homozygous familial hypercholesterolemia (AR-HoFH) is a severe lipid disorder leading to early-onset atherosclerotic cardiovascular disease (ASCVD) due to extreme low-density lipoprotein cholesterol (LDL-C) elevations.…
Preview only. Read the full abstract at the source